Developing a Versatile Arsenal: Novel Antimicrobials as Offensive Tools Against Pathogenic Bacteria.

Area of Science:

• Microbiology
• Biotechnology
• Public Health

Background:

• Antibiotic resistance is a critical global health crisis driven by widespread antibiotic use.
• Existing strategies to combat antimicrobial resistance are insufficient.
• Novel antimicrobial approaches are urgently needed.

Purpose of the Study:

• To review innovative antimicrobial strategies for combating drug-resistant bacteria.
• To provide a comprehensive analysis of emerging techniques, with a focus on CRISPR/Cas systems.
• To explore theoretical advancements and delivery methods for new antimicrobial agents.

Main Methods:

• Literature review of cutting-edge antimicrobial technologies.
• In-depth analysis of CRISPR/Cas-based antimicrobials, including mechanisms, applications, advantages, and limitations.
• Exploration of nano-antimicrobials, ribosomal protein-derived antimicrobials, bioenergetic disruptors, and antimicrobial polysaccharides.
• Discussion of theoretical advancements and delivery systems for novel antimicrobials.

Main Results:

• Several innovative antimicrobial strategies show significant promise, including nano-antimicrobials, CRISPR/Cas systems, bioenergetic agents, and antimicrobial polysaccharides.
• CRISPR/Cas-based antimicrobials offer precise targeting and unique advantages but also present limitations.
• Novel approaches have the potential to revolutionize the treatment of bacterial infections.

Conclusions:

• The development of groundbreaking antimicrobial strategies is paramount to address the escalating threat of antimicrobial resistance.
• CRISPR/Cas systems represent a powerful tool with potential for broad biomedical applications.
• Further research into multimodal therapeutic strategies and effective delivery systems is essential for future success.